MD considers funds for growing nano-biotech field

Maryland lawmakers are considering a bill that could pump between $5 million and $10 million next year into a program to support the development of nano-biotech companies. Nanotechnology, the science of the very small, has increasingly been a focus of researchers exploring new ways to develop and deliver therapies. Maryland, the home to leading research groups operating close to Washington D.C., hopes that a relatively small amount of money could have a big impact on its efforts to attract researchers and new biotech businesses to the state.

"This investment will enable our state to bring the best talent to Maryland to build on our current strength to leverage new grants," William Kirwan, chancellor of the University System of Maryland, told the AP.

- read the AP report

Suggested Articles

Halozyme CEO Helen Torley discusses how the company stayed alive after its lead program, a treatment for pancreatic cancer, failed in phase 3.

The under-active genes that cause heart problems and poor muscle movement in Down syndrome may also impede the growth of solid tumors, a study found.

The new funding will bankroll Dyne's preclinical programs in three muscle-wasting diseases, as well as discovery-stage work.